This information is current as
of June 15, 2017.
Improved protection against disseminated
tuberculosis by Mycobacterium bovis bacillus
Calmette-Guérin secreting murine GM-CSF
is associated with expansion and activation of
APCs
A. A. Ryan, T. M. Wozniak, E. Shklovskaya, M. A.
O'Donnell, B. Fazekas de St. Groth, W. J. Britton and J. A.
Triccas
Subscription
Permissions
Email Alerts
Information about subscribing to The Journal of Immunology is online at:
http://jimmunol.org/subscription
Submit copyright permission requests at:
http://www.aai.org/About/Publications/JI/copyright.html
Receive free email-alerts when new articles cite this article. Sign up at:
http://jimmunol.org/alerts
The Journal of Immunology is published twice each month by
The American Association of Immunologists, Inc.,
1451 Rockville Pike, Suite 650, Rockville, MD 20852
Copyright © 2008 by The American Association of
Immunologists All rights reserved.
Print ISSN: 0022-1767 Online ISSN: 1550-6606.
Downloaded from http://www.jimmunol.org/ by guest on June 15, 2017
J Immunol 2008; 180:7047; ;
doi: 10.4049/jimmunol.180.10.7047
http://www.jimmunol.org/content/180/10/7047.1
The Journal of Immunology
CORRECTIONS
Ryan, A. A., T. M. Wozniak, E. Shklovskaya, M. A. O’Donnell, B. Fazekas de St. Groth, W. J. Britton, and J. A.
Triccas. 2007. Improved protection against disseminated tuberculosis by Mycobacterium bovis bacillus CalmetteGuérin secreting murine GM-CSF is associated with expansion and activation of APCs. J. Immunol. 179:
8418 – 8424.
The term “BCG-secreting” and “BCG-expressing” should not be hyphenated in the following occurrences: the
abbreviations used in this paper footnote, the running title, the sixth and thirteenth sentence of the Abstract, the last
and penultimate sentence of the Introduction on page 8419, and the first sentence of the third paragraph of the
Discussion on page 8423.
In Material and Methods in the second paragraph under the heading Bacterial strains and growth conditions on page
8419, “residues 230 –259 of OVA” in the second sentence should read “residues 230 –359 of OVA” and in the third
sentence “OVA250 –345” should read “OVA230 –359” in the same paragraph.
Rankin, A. L., A. J. Reed, S. Oh, C. Cozzo Picca, H. M. Guay, J. Larkin, III, L. Panarey, M. K. Aitken, B. Koeberlein,
P. E. Lipsky, J. E. Tomaszewski, A. Naji, and A. J. Caton. 2008. CD4⫹ T cells recognizing a single self-peptide expressed
by APCs induce spontaneous autoimmune arthritis. J. Immunol. 180: 833– 841.
There are typographical errors in the Fig. 2 and Fig. 5 legends. The errors have no bearing on the conclusions or
interpretations of the data.
In the Fig. 2 legend, the penultimate sentence should read: “Dot plots show expression of 6.5 vs CFSE on CD4⫹
splenocytes 3 days posttransfer (left panels), and histograms show expression of MHC class II and CD86 on B220⫹ cells
from BALB/c, HA104, and HACII mice that received TS1 LN cells (black lines), and from unmanipulated BALB/c,
HA104, and HACII mice (gray lines).”
The second sentence of the Fig. 5 legend should read: “A, Histograms show CD69, CD44, and CD45RB expression by
6.5⫹CD4⫹ splenocytes from ⱖ12-wk-old TS1 (gray lines/font), TS1 ⫻ HA104 (dashed lines/black font), and TS1 ⫻
HACII (black lines/bold font) mice, with the mean percentage of cells in the indicated gates shown (n ⱖ 3 mice per
genotype).
Douin-Echinard, V., S. Laffont, C. Seillet, L. Delpy, A. Krust, P. Chambon, P. Gourdy, J.-F. Arnal, and J.-C. Guéry. 2008.
Estrogen receptor ␣, but not ␤, is required for optimal dendritic cell differentiation and of CD40-induced cytokine
production. J. Immunol. 180: 3661–3669.
In the title, the word “of” preceding “CD40-induced” appears in error in the print version and in the online PDF. The
online full text version is correct. The title should read: “Estrogen Receptor ␣, but Not ␤, Is Required for Optimal
Dendritic Cell Differentiation and CD40-Induced Cytokine Production.”
Sahu, N., C. Mueller, A. Fischer, and A. August. 2008. Differential sensitivity to Itk kinase signals for T helper 2 cytokine
production and chemokine-mediated migration. J. Immunol. 180: 3833–3838.
Copyright © 2008 by The American Association of Immunologists, Inc. 0022-1767/08/$2.00
www.jimmunol.org
Downloaded from http://www.jimmunol.org/ by guest on June 15, 2017
In the Fig. 4 legend, “residues 230 –259 of the OVA protein” should read “residues 230 –359 of the OVA protein.”
7048
CORRECTIONS
The authors want to correct the NFAT nomenclature used in their article. In all instances discussed, the authors
analyzed NFAT-c1/NFAT2 rather than NFAT-c2/NFAT1 as indicated in the text and figures. Thus, any references
to NFAT-c2/NFAT1 should read NFAT-c1/NFAT2. This change does not affect the conclusions drawn from any of
the data presented in the article. The authors regret any confusion this may cause to readers.
Madakamutil, L. T., I. Maricic, E. E. Sercarz, and V. Kumar. 2008. Immunodominance in the TCR repertoire of ␣TCR
peptide-specific CD4⫹ Treg population that controls experimental autoimmune encephalomyelitis. J. Immunol. 180:
4577– 4585.
In the title, the Greek symbol “␣” preceding “TCR Peptide-Specific” should be the word “a” followed by a space. The
title should read: “Immunodominance in the TCR Repertoire of a TCR Peptide-Specific CD4⫹ Treg Population That
Controls Experimental Autoimmune Encephalomyelitis.”
Downloaded from http://www.jimmunol.org/ by guest on June 15, 2017